Finch Therapeutics Group, Inc. (FNCHQ)
OTCMKTS · Delayed Price · Currency is USD
7.50
0.00 (0.00%)
Jun 15, 2026, 9:30 AM EST
Finch Therapeutics Group Market Cap
Finch Therapeutics Group has a market cap or net worth of $12.04 million as of June 16, 2026. Its market cap has decreased by -32.74% in one year.
Market Cap
12.04M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$7.50
Market Cap Chart
Since March 19, 2021, Finch Therapeutics Group's market cap has decreased from 1.01B to 12.04M, a decrease of -98.80%. That is a compound annual growth rate of -56.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 12.04M | -44.39% |
| Dec 31, 2025 | 21.66M | 19.35% |
| Dec 31, 2024 | 18.15M | 213.02% |
| Dec 29, 2023 | 5.80M | -74.79% |
| Dec 30, 2022 | 22.99M | -95.14% |
| Dec 31, 2021 | 473.36M | -52.91% |
| Mar 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ZIVO Bioscience | 15.32M |
| Inhibitor Therapeutics | 14.75M |
| Galera Therapeutics | 13.97M |
| Zeo ScientifiX | 13.22M |
| LianBio | 11.96M |
| Curative Biotechnology | 11.01M |
| Nymox Pharmaceutical | 10.20M |
| Biomind Labs | 9.31M |